The Global Renin-Inhibitors Market was valued at 70.79 Million USD in 2020 and will grow with a CAGR of 6% during the forecast period 2022 to 2028.
Renin inhibitors are medicines that reduce the formation of geotensin II, which lowers blood pressure by inhibiting the activity of renin, which is responsible for the hydrolysis of geotensinogen to geotensin I. Renin is a proteolytic enzyme secreted in response to sympathetic activation, decreased sodium transport, and hypotension from the kidney to the distal tubule. It converts angiotensinogen to angiotensin I later by angiotensin converting enzyme. Angiotensin II is a potent vasoconstrictor that raises blood pressure. Renin inhibitors block the activity of renin and induce vasodilation, and are called a group of drugs mainly used for the treatment of essential hypertension. First- and second-generation drugs faced problems such as low bioavailability and lack of efficacy, but third-generation drugs allowed oral bioavailability and were robust enough for clinical use. Aliskiren (INN) is the first in a class of drugs called direct renin inhibitors. The currently approved indication is essential (primary) hypertension.
(Get 15% Discount on Buying this Report)
A full report of Global Renin-Inhibitors Market is available at: https://orionmarketreports.com/renin-inhibitors-market/105748/
Market Segments
By Product Type
- 150mg/Tablet
- 300mg/Tablet
By Application
- Below 45
- 46-55
- 55-65
- Above 66
Key Players
- Johnson & Johnson
- Pfizer
- Bio-Rad Laboratories Inc.
- Sanofi
- Lupin
- Merck & Co.
- Astra Zeneca
- Daiichi Sankyo
- Novartis
Scope of the Report
The research study analyzes the global Renin-Inhibitors industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Renin-Inhibitors Market Report
1. What was the Renin-Inhibitors Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Renin-Inhibitors Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Renin-Inhibitors Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Renin-Inhibitors market.
- The market share of the global Renin-Inhibitors market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Renin-Inhibitors market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Renin-Inhibitors market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
